Provider of home health, hospice and private-duty nursing services, focused heavily on pediatric home care.
Provider of home health, hospice and private-duty nursing services, focused heavily on pediatric home care.
Paid mostly by state Medicaid programs, which set the hourly rates for nursing visits in children's homes, with Medicare paying set amounts for home health and hospice. Results therefore depend on state rate decisions and on how many nurses it can hire and keep. Bain Capital owned it before its 2021 listing.
Moat: narrow (scale, regulatory licence). Largest pediatric private-duty nursing provider in a heavily state-regulated, labor-constrained industry.
Headquarters: Atlanta, Georgia · Founded: 1999 · Employees: 35,500
Size Aveanna Healthcare (AVAH) is a United States Health Care company (Medical/Nursing Services) with a market value of $2.37B, the 1674th largest of 3,085 United States companies the cockpit tracks. Shares closed at $10.85 on 18 Nov 2026.
Performance Over six months the shares gained 41.2%, against +19.1% for the median peer and -2.2% for the United States market (cap-weighted) — 5th highest of 21 in its peer set.
Growth Revenue grew 16.8% over the last twelve months (peer median +4.6%); the operating margin is 12.3% (peer median 7.6%).
Valuation It trades at 12.2× forward earnings against a peer median of 37.6× (cheapest of 17).
Price implies For today's price to make sense, revenue must grow about 8% a year for seven years (Req g). Recent delivered growth is +10%, so the hurdle is -3 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 4.0 points above its cost of capital (11.4% WACC).
Short interest Short interest is 3.3% of the free float (30 Oct 2026).
Next results Next results expected around 18 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | $2.68B | $2.43B | $2.02B | $1.90B | $1.79B |
| Revenue growth | — | +20% | +7% | +6% | — |
| Gross profit | $852M | $800M | $625M | $582M | $532M |
| EBITDA | $359M | $296M | $182M | $144M | $118M |
| Net income | $306M | $225M | -$10.9M | -$135M | -$662M |
| Free cash flow | $198M | $115M | $24.1M | $16.6M | -$60.4M |
| Capital expenditure | $9.70M | $7.45M | $6.32M | $6.12M | $12.0M |
| Total debt | $1.54B | $1.51B | $1.50B | $1.50B | $1.50B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Aveanna Healthcare AVAH | $2.37B | +41% | +17% | 12% | 12.2× | 7.7% |
| Addus HomeCare ADUS | $2.25B | +29% | +12% | 11% | 16.2× | 4.0% |
| Encompass Health EHC | $13.2B | +27% | +9% | 18% | 20.1× | 5.7% |
| BrightSpring Health Services BTSG | $13.6B | +17% | +23% | 4% | 28.8× | 24.9% |
| Pennant PNTG | $1.26B | +1% | +39% | 6% | 23.7× | 20.7% |
| Chemed CHE | $7.12B | +24% | +5% | 14% | 20.2× | 3.3% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | AVAH | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -14.9% | -0.3% | 2nd lowest of 21 |
| 6-month return | +41.2% | +19.1% | 5th highest of 21 |
| Distance from 52-week high | -26.3% | -13.7% | 8th lowest of 21 |
| Revenue growth (TTM) | +16.8% | +4.6% | 5th highest of 21 |
| Operating margin | 12.3% | 7.6% | 4th highest of 21 |
| Forward P/E | 12.2× | 37.6× | cheapest of 17 |
| Growth the price implies (Req g, 7 yrs) | 7.7% | 12.5% | 8th least demanding of 15 |
| Growth delivered (Del g) | +10.2% | +10.1% | 8th highest of 15 |
| Hurdle (Req g minus delivered) | -2.5 pp | +3.9 pp | 5th least demanding of 15 |
| ROIC minus cost of capital | +4.0 pp | -1.6 pp | 4th highest of 20 |
| EV / EBITDA | 10.4× | 12.1× | 4th cheapest of 14 |
| Net debt / EBITDA | 3.8× | 2.2× | 6th most indebted of 15 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Aveanna Healthcare AVAH | United States | $2.37B | +41% | +17% | 12% | 12.2× | 7.7% | +10.2% |
| Pediatrix Medical MD | United States | $2.41B | +37% | +2% | 12% | 12.4× | -4.4% | +2.0% |
| Addus HomeCare ADUS | United States | $2.25B | +29% | +12% | 11% | 16.2× | 4.0% | +13.2% |
| Meinian Onehealth Healthcare 002044.SZ | China | $2.60B | -27% | -4% | 9% | 49.6× | 4.2% | +5.7% |
| AddLife ALIF-B.ST | Sweden | $2.13B | +15% | +2% | 8% | 39.0× | 21.1% | +14.6% |
| Azenta AZTA | United States | $2.03B | +162% | +5% | -2% | 83.2× | 38.0% | +3.9% |
| NeoGenomics NEO | United States | $1.98B | +72% | +11% | -6% | 53.5× | n/a | n/a |
| Dr. Agarwal's Health Care AGARWALEYE.NS | India | $1.86B | +20% | +26% | 15% | 77.1× | 43.0% | +26.9% |
| Guangzhou Kingmed Diagnostics 603882.SS | China | $1.86B | +5% | -3% | 7% | 29.9× | 5.4% | -6.1% |
| Emeis EMEIS.PA | France | $1.78B | -33% | +4% | 3% | n/a | 21.2% | +8.5% |
| Dian Diagnostics 300244.SZ | China | $1.70B | +1% | -5% | 9% | 21.8× | 0.3% | -1.1% |
| Vijaya Diagnostic Centre VIJAYA.NS | India | $1.69B | +18% | +24% | 32% | 63.0× | 40.4% | +16.7% |
| Personalis PSNL | United States | $1.62B | +88% | +17% | -157% | n/a | n/a | n/a |
| Acadia Healthcare ACHC | United States | $3.49B | +56% | +4% | 10% | 18.6× | n/a | n/a |
| Sonida Senior Living SNDA | United States | $1.59B | -11% | +70% | -8% | n/a | n/a | n/a |
| Ambea AMBEA.ST | Sweden | $1.59B | +28% | +11% | 9% | 15.2× | 1.1% | +7.7% |
| Dr. Lal PathLabs LALPATHLAB.NS | India | $3.53B | +15% | +17% | 24% | 50.5× | 32.3% | +11.8% |
| GeneDx WGS | United States | $1.56B | +16% | +15% | -14% | 54.2× | n/a | n/a |
| agilon health AGL | United States | $1.52B | +12% | +2% | -2% | 34.1× | n/a | n/a |
| Teladoc Health TDOC | United States | $1.47B | +24% | -2% | -5% | n/a | -6.4% | +18.3% |
| Medicover MCOV-B.ST | Sweden | $3.87B | +21% | +3% | 7% | 36.1× | 19.6% | +20.2% |